View Clinical Trial (Medical Research Study)
Open-Label Study of Oral Treprostinil in Digital Ulcers - NCT00848107-80204(Clinical Trial 273442)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Denver |
|
State:
|
|
CO |
| Zip Code: |
|
80204 |
| Conditions: |
|
Systemic Sclerosis |
| Purpose: |
|
This open label extension trial will allow ongoing treatment of subjects who participated in
the randomized controlled trials, and will provide long term information about the safety of
treprostinil diethanolamine SR in this patient population
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Eligible subjects who completed assessments for the final visit of the previous
controlled trials and who signed appropriate informed consent are eligible to enroll
in this extension study.
- If a female of childbearing potential, the subject must agree to continue practicing
an acceptable method of birth control (i.e., surgical sterilization, approved
hormonal contraceptives, barrier methods [such as a condom or diaphragm] used with a
spermicide, or an intrauterine device).
Exclusion Criteria:
- Have had any change in clinical status that, in the opinion of the Investigator,
would pose a safety risk for participation in this extension study;
- Have been found to be unable to complete study assessments in the previous controlled
trial;
- Have prematurely discontinued study drug during the previous study |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
January 5, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|